RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aceso Life Science Group Stock

Aceso Life Science Group EBIT 2024

Aceso Life Science Group EBIT

19 M HKD

Ticker

474.HK

ISIN

KYG0070S1066

In 2024, Aceso Life Science Group's EBIT was 19 M HKD, a -75.95% increase from the 79 M HKD EBIT recorded in the previous year.

The Aceso Life Science Group EBIT history

YEAREBIT (undefined HKD)
202419
202379
202245
202175
202075.27
2019-16
2018-69.99
20172.81
201641.86
2015-7.32
2014-35.1
2013-59.9
2012-48.1
2011-47.8
2010-19.1
20097.8
200821.8
200728.2
200623.2
200529.7

Aceso Life Science Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Aceso Life Science Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aceso Life Science Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aceso Life Science Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Aceso Life Science Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Aceso Life Science Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Aceso Life Science Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aceso Life Science Group’s growth potential.

Aceso Life Science Group Revenue, EBIT and net profit per share

DateAceso Life Science Group RevenueAceso Life Science Group EBITAceso Life Science Group Net Income
2024228 M undefined19 M undefined-462 M undefined
2023312 M undefined79 M undefined-264 M undefined
2022315 M undefined45 M undefined-370 M undefined
2021346 M undefined75 M undefined-376 M undefined
2020295.65 M undefined75.27 M undefined-283.72 M undefined
2019319.51 M undefined-16 M undefined-380.87 M undefined
2018330.02 M undefined-69.99 M undefined-444.91 M undefined
2017206.31 M undefined2.81 M undefined-3.08 B undefined
2016129.99 M undefined41.86 M undefined524.4 M undefined
201560.9 M undefined-7.32 M undefined1.52 B undefined
201440.3 M undefined-35.1 M undefined-12.4 M undefined
20130 undefined-59.9 M undefined-219.3 M undefined
2012140.2 M undefined-48.1 M undefined-378.5 M undefined
2011122.1 M undefined-47.8 M undefined-96.6 M undefined
201097 M undefined-19.1 M undefined-469.4 M undefined
2009166.5 M undefined7.8 M undefined-22.9 M undefined
2008176.8 M undefined21.8 M undefined22.2 M undefined
2007156.5 M undefined28.2 M undefined28.1 M undefined
2006151.1 M undefined23.2 M undefined26.8 M undefined
2005130.6 M undefined29.7 M undefined30.2 M undefined

Aceso Life Science Group stock margins

The Aceso Life Science Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aceso Life Science Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aceso Life Science Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Aceso Life Science Group's sales revenue. A higher gross margin percentage indicates that the Aceso Life Science Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Aceso Life Science Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Aceso Life Science Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aceso Life Science Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aceso Life Science Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aceso Life Science Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Aceso Life Science Group Margin History

Aceso Life Science Group Gross marginAceso Life Science Group Profit marginAceso Life Science Group EBIT marginAceso Life Science Group Profit margin
202451.32 %8.33 %-202.63 %
202345.19 %25.32 %-84.62 %
202251.43 %14.29 %-117.46 %
202161.56 %21.68 %-108.67 %
202056.35 %25.46 %-95.97 %
201947.99 %-5.01 %-119.2 %
201844.16 %-21.21 %-134.81 %
201782.2 %1.36 %-1,492.34 %
201651.32 %32.2 %403.43 %
201551.32 %-12.01 %2,500.15 %
201451.32 %-87.1 %-30.77 %
201351.32 %0 %0 %
201225.18 %-34.31 %-269.97 %
201115.56 %-39.15 %-79.12 %
201011.75 %-19.69 %-483.92 %
200922.76 %4.68 %-13.75 %
200831.45 %12.33 %12.56 %
200736.87 %18.02 %17.96 %
200638.25 %15.35 %17.74 %
200542.73 %22.74 %23.12 %

Aceso Life Science Group Aktienanalyse

What does Aceso Life Science Group do?

Aceso Life Science Group Ltd is a UK-based company specializing in the field of medical cannabis. The company was founded in 2016 when the founders recognized the growing demand for medical cannabis and decided to utilize their expertise in this area to establish a company focused on the development and marketing of cannabis products. Aceso's business model is based on various pillars. On one hand, the company offers product design and research and development in the field of medical cannabis products. Aceso also provides various services to help other companies and research institutions develop and bring their own commercial products to market. The company also has a strong presence in retail, where it offers a wide range of cannabinoid products. Aceso Life Science Group has various divisions that focus on the production of medical cannabis products. This includes the manufacturing of medical cannabinoids, which involves the preparation of cannabis oil and other products. Aceso also offers various types of medical cannabis, such as different THC and CBD-based products, and has also developed a special line of products targeting women. Aceso also has a strong presence in research and development, with a dedicated department focused on the development of new and improved cannabinoid products. Aceso's research department works closely with academic research institutions and other organizations to investigate and improve the efficacy and safety of medical cannabis and its derivatives. The products offered by Aceso primarily include medical oils, capsules, tinctures, and creams. These products contain a wide range of cannabinoids, such as CBD, THC, CBG, and CBN, which can be used to treat various conditions. Aceso has also developed a special series of products targeting women, including specific vaginal creams that can be used to treat pain and discomfort associated with the menstrual cycle and other conditions. Overall, Aceso Life Science Group Ltd has established itself as a leading company in the field of medical cannabis products. The company has developed a wide range of products and services aimed at providing its customers with a safe and effective way to treat various conditions. With a strong retail presence and a dedicated research department, Aceso has everything it needs to continue to play a pioneering role in the medical cannabis industry. Aceso Life Science Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Aceso Life Science Group's EBIT

Aceso Life Science Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Aceso Life Science Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Aceso Life Science Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Aceso Life Science Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Aceso Life Science Group stock

How much did Aceso Life Science Group achieve in EBIT for the current year?

In the current year, Aceso Life Science Group has achieved an EBIT of 19 M HKD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Aceso Life Science Group.

How has the EBIT of Aceso Life Science Group developed in recent years?

The EBIT of Aceso Life Science Group has increased by -75.949% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Aceso Life Science Group?

The EBIT of Aceso Life Science Group is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Aceso Life Science Group pay?

Over the past 12 months, Aceso Life Science Group paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 34.55 %. For the coming 12 months, Aceso Life Science Group is expected to pay a dividend of 0 HKD.

What is the dividend yield of Aceso Life Science Group?

The current dividend yield of Aceso Life Science Group is 34.55 %.

When does Aceso Life Science Group pay dividends?

Aceso Life Science Group pays a quarterly dividend. This is distributed in the months of September, September, September, September.

How secure is the dividend of Aceso Life Science Group?

Aceso Life Science Group paid dividends every year for the past 0 years.

What is the dividend of Aceso Life Science Group?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aceso Life Science Group located?

Aceso Life Science Group is assigned to the 'Finance' sector.

Wann musste ich die Aktien von Aceso Life Science Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aceso Life Science Group from 9/2/2009 amounting to 0.012 HKD, you needed to have the stock in your portfolio before the ex-date on 8/14/2009.

When did Aceso Life Science Group pay the last dividend?

The last dividend was paid out on 9/2/2009.

What was the dividend of Aceso Life Science Group in the year 2023?

In the year 2023, Aceso Life Science Group distributed 0 HKD as dividends.

In which currency does Aceso Life Science Group pay out the dividend?

The dividends of Aceso Life Science Group are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aceso Life Science Group

Our stock analysis for Aceso Life Science Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aceso Life Science Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.